References

Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis

10.1371/journal.pone.0177113 · 2017 · External reference

Early signals of vaccine-driven perturbation seen in pneumococcal carriage population genomic data

10.1093/cid/ciz404 · 2020 · External reference

Capsular polysaccharide (CPS) release by serotype 3 pneumococcal strains reduces the protective effect of anti-type 3 CPS antibodies

10.1128/cvi.00591-15 · 2016 · External reference

Performance standards for antimicrobial susceptibility testing

2023 · External reference

Rapid pneumococcal evolution in response to clinical interventions

10.1126/science.1198545 · 2011 · External reference

Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins

10.1093/nar/gku1196 · 2015 · External reference

Decline in pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in children in Atlanta, Georgia

10.1097/inf.0000000000000849 · 2015 · External reference

International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact

10.2139/ssrn.3360095 · 2019 · External reference

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event

10.1038/ng.1072 · 2012 · External reference

Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain

10.1016/j.cmi.2019.10.034 · 2020 · External reference

Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries

10.1080/13696998.2021.1970975 · 2021 · External reference

Nonencapsulated Streptococcus pneumoniae: Emergence and pathogenesis

10.1128/mbio.01792-15 · 2016 · External reference

Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: A United States perspective

10.1128/cmr.00058-15 · 2016 · External reference

Use of 21-valent pneumococcal conjugate vaccine among U.S. adults: Recommendations of the Advisory Committee on Immunization Practices - United States 2024

10.15585/mmwr.mm7336a3 · 2024 · External reference

Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: An international whole-genome sequencing study

10.1016/s1473-3099(19)30297-x · 2019 · External reference

Sugar-coated killer: Serotype 3 pneumococcal disease

10.3389/fcimb.2020.613287 · 2020 · External reference

Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction, (2011-2016): Surveillance data from 23 sites in Catalonia, Spain

10.1371/journal.pone.0228612 · 2020 · External reference

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance

10.1111/j.1469-0691.2011.03570.x · 2012 · External reference

Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine

10.1016/j.diagmicrobio.2014.05.020 · 2014 · External reference

Invasive pneumococcal disease in the Gulf region: A narrative review of incidence, burden, and vaccine strategies

10.3389/fpubh.2025.1589366 · 2025 · External reference

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: Analysis of multisite, population-based surveillance

10.1016/s1473-3099(14)71081-3 · 2015 · External reference

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates

10.1016/s0140-6736(09)61204-6 · 2009 · External reference

Whole-genome analysis revealed antimicrobial resistance and virulence-associated genome features in environmental Salmonella enterica isolates from creek sediments in the Mid-Atlantic United States

10.3390/microbiolres17040072 · 2026 · External reference

Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States

10.1128/aac.03344-14 · 2014 · External reference

Emergence of Streptococcus pneumoniae serotype 12F after sequential introduction of 7- and 13-valent vaccines, Israel

10.3201/eid2403.170769 · 2018 · External reference

Antimicrobial resistance in Streptococcus pneumoniae: A retrospective analysis of emerging trends in the United Arab Emirates from 2010 to 2021

10.3389/fpubh.2023.1244357 · 2023 · External reference

Rebound of pediatric invasive pneumococcal disease in Portugal after the COVID-19 pandemic was not associated with significant serotype changes

10.1016/j.jinf.2024.106242 · 2024 · External reference

Invasive pneumococcal disease in adults in Portugal: The importance of serotypes 8 and 3 (2015-2018)

10.3390/microorganisms9051016 · 2021 · External reference

Genomic surveillance of invasive Streptococcus pneumoniae strains in South Tunisia during 2012-2022

10.1099/mgen.0.001448 · 2025 · External reference

Serotype replacement in disease after pneumococcal vaccination

10.1016/s0140-6736(10)62225-8 · 2011 · External reference

Validation and application of long-read whole-genome sequencing for antimicrobial resistance gene detection and antimicrobial susceptibility testing

10.1128/aac.01072-22 · 2023 · External reference

Pneumococcal capsular switching: A historical perspective

10.1093/infdis/jis703 · 2013 · External reference

Serotype distribution and antimicrobial resistance in pediatric invasive pneumococcal pneumonia: A laboratory surveillance study from Argentina 2022-2024

10.1016/j.vaccine.2025.128128 · 2026 · External reference